Develops 3-dimensional tissues for bone defects
Novadip Biosciences has raised €87M across 3 funding rounds from 10 investors, most recently a Series B round in Nov 2022. Based in Ottignies-Louvain-la-Neuve, Belgium; founded 2013; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-11-04 | Series B | €40M | Pierre Drion,CR-CP Life Science Fund,Fund plus,InvestSud,New Science Ventures,Olivier van der Rest+3 more | View deal → |
| 2021-11-28 | Series B | €19M | CR-CP Life Science Fund,Fund plus,Invest BW,InvestSud,New Science Ventures,SRIW Life Sciences+1 more | View deal → |
| 2015-09-01 | Series A | €28M | — | View deal → |
